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OBJECTIVES The objective of this study was to compare stentless bioprostheses with stented bioprostheses
with regard to their hemodynamic behavior during exercise.
BACKGROUND Stentless aortic bioprostheses have better hemodynamic performances at rest than stented
bioprostheses, but very few comparisons were performed during exercise.
METHODS Thirty-eight patients with normally functioning stentless (n 5 19) or stented (n 5 19)
bioprostheses were submitted to a maximal ramp upright bicycle exercise test. Valve effective
orifice area and mean transvalvular pressure gradient at rest and during peak exercise were
successfully measured using Doppler echocardiography in 30 of the 38 patients.
RESULTS At peak exercise, the mean gradient increased significantly less in stentless than in stented
bioprostheses (15 6 3 vs. 112 6 8 mm Hg; p 5 0.002) despite similar increases in mean
flow rates (1137 6 58 vs. 1125 6 65 ml/s; p 5 0.58); valve area also increased but with no
significant difference between groups. Despite this hemodynamic difference, exercise capacity
was not significantly different, but left ventricular (LV) mass and function were closer to
normal in stentless bioprostheses. Overall, there was a strong inverse relation between the
mean gradient during peak exercise and the indexed valve area at rest (r 5 0.90).
CONCLUSIONS Hemodynamics during exercise are better in stentless than stented bioprostheses due to the
larger resting indexed valve area of stentless bioprostheses. This is associated with beneficial
effects with regard to LV mass and function. The relation found between the resting indexed
valve area and the gradient during exercise can be used to project the hemodynamic behavior
of these bioprostheses at the time of operation. It should thus be useful to select the optimal
prosthesis given the patient’s body surface area and level of physical activity. (J Am Coll
Cardiol 1999;34:1609–17) © 1999 by the American College of Cardiology
Recent studies (1,2) showed that stentless aortic biopros-
theses have better hemodynamic performance at rest than
their stented counterparts, and this is believed to be
related to the stentless design that provides a larger
effective orifice area (EOA) for the same prosthesis outer
diameter size. Also, our team recently showed that during
maximal exercise in stented bioprostheses, the increase in
gradient is mainly determined by the indexed EOA at
rest (3). Therefore, we hypothesized that stentless bio-
prostheses would have less increase in gradient during
exercise in comparison with stented bioprostheses due to
their larger resting indexed EOAs. We also hypothesized
that the stentless bioprostheses might have the added
advantage of increasing their EOA during exercise to a
relatively greater extent than stented bioprostheses due to
a possible expansion of the prosthesis valvular annulus.
To our knowledge, there have been few studies of the
hemodynamic behavior of stentless valves during exercise
(4,5).
The objective of this study was, therefore, to compare the
hemodynamic behavior of stentless and stented aortic bio-
prostheses during maximal exercise in comparable groups of
patients. Because the hemodynamic behavior of the pros-
thesis could also influence the remodeling of the left
ventricle (LV) after valve replacement, a secondary objective
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of the study was to compare the parameters of LV mor-
phology and function in these two groups of patients.
METHODS
Patients. Fifty patients, 11 female and 39 male, with either
a stented or a stentless bioprosthetic valve in the aortic
position were randomly selected for the study. Of the 27
patients included in the stented valve group, 22 received a
Medtronic Intact valve (Medtronic, Minneapolis, Minne-
sota), 2 received a Medtronic Mosaic valve, 2 received a
Carpentier-Edwards pericardial valve (Baxter, Irvine, Cali-
fornia) and 1 received a St-Jude X-Cell valve (St-Jude
Medical, St. Paul, Minnesota). All the patients (n 5 23) in
the stentless valve group received a Medtronic Freestyle
valve. The valve was implanted using the subcoronary
technique in 22 patients and the root replacement technique
in one patient. A complete Doppler echocardiographic
evaluation was first performed at rest with the patient in the
supine position to verify that all patients had a normal LV
systolic function (ejection fraction .50%) and no evidence
of prosthetic valve dysfunction. The protocol was approved
by the authors’ institutional review board, and all subjects
gave informed written consent. Some of the data from the
patients with a stented valve have been reported in a
previous study (3).
Echocardiographic assessment of LV morphology and
function at rest. Doppler echocardiographic examinations
were performed with a Hewlett Packard Sonos 2000 Ultra-
sound system (Hewlett Packard, Andover, Massachusetts).
From a parasternal LV long-axis view, standard recordings
of two-dimensionally directed LV M-mode echocardio-
grams were obtained at rest with the patient in the left
lateral decubitus position. Left ventricular minor axis inter-
nal dimension, posterior wall and septal thickness were
measured at end-diastole and end-systole. Left ventricular
mass was calculated using the corrected formula of the
American Society of Echocardiography and was indexed for
body surface area (6). The shortening fraction of the
internal radius, the mid-wall radius and the length of the
LV, as well as the fraction and velocity of the posterior wall
thickening, were determined using the model proposed by
Dumesnil et al. (7). The ejection fraction was calculated
using the mid-wall radius and the longitudinal shortening
fractions as previously described (8).
The peak systolic wall stress was estimated by the method
of Grossman et al. (9):
Wall stress 5
~LVPs 3 LVIDs!
2 3 SLVPWTs 3 S1 1 LVPWTs2 3 LVIDsDD
where LVIDs and LVPWTs are the internal dimension and
the posterior wall thickness of the LV at end-systole,
respectively, and LVPs is the approximated LV systolic
pressure, calculated by adding the systolic blood pressure
and the peak transprosthetic gradient obtained from con-
tinuous wave Doppler recordings of the aortic jet velocity.
Exercise protocol. Patients were submitted to a maximal
ramp upright bicycle exercise test beginning with an initial
workload of 0 W, followed by continuous increments of 10
W/min. A 12-lead electrocardiogram was continuously
recorded and blood pressure was measured every 2 min. The
patients were encouraged to exercise until exhaustion or the
appearance of symptoms. The test was stopped if there was
an abnormal rise in blood pressure (diastolic pressure
.110 mm Hg), ECG evidence of ischemia (.1 mm
horizontal or downsloping S-T depression 0.08 s after the J
point compared with the resting ECG) or significant
arrhythmia. Respiratory gas analysis was carried out with a
Q-Plex 1 system (Quinton Instrument Co., Bothel, Wash-
ington) to measure oxygen consumption (VO2) and CO2
production. Results were averaged over five breaths. Peak
oxygen consumption was defined as the highest value of
VO2 obtained at the end of the test. The percentage of the
predicted peak VO2 for a given patient’s age and gender was
calculated from the mean values of peak VO2 in the normal
population (10). The anaerobic threshold was determined
by two experienced observers using the V-slope method
(11). Patients were considered to have reached their cardio-
respiratory maximum if the respiratory exchange ratio was
$1.10 or if it was $1.05 and the VO2 had leveled off at the
end of the test (12).
Doppler echocardiographic measurements during exer-
cise. Doppler echocardiographic examinations were per-
formed with the patient sitting on the bicycle: 1) at rest, and
2) at peak of maximal exercise just before stopping the test
or within 2 min after test termination. Measurements
performed at rest in the upright position included the
transvalvular flow velocity using continuous wave Doppler,
LV outflow tract (LVOT) flow velocity using pulsed-wave
Doppler and LVOT diameter, as previously described
(1,13,14). The same measurements were performed during
exercise except for LVOT diameter which was assumed to
have remained constant (15). The velocity recording was
first performed in the transvalvular jet and then in the
LVOT. From these measurements, we calculated the LV
stroke volume from the product of the LVOT velocity-time
integral and cross-sectional area, the cardiac output from
the product of stroke volume and heart rate, the mean
transvalvular flow rate from the quotient of stroke volume
and systolic ejection time, the mean transvalvular pressure
gradient using the modified Bernoulli equation with inclu-
Abbreviations and Acronyms
EOA 5 effective orifice area
LV 5 left ventricular or ventricle
LVOT 5 left ventricular outflow tract
VO2 5 oxygen consumption
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sion of subvalvular velocity and the EOA using the standard
continuity equation. If the difference in heart rate between
the time of transvalvular velocity recording and that of
LVOT velocity recording was .5%, the data was rejected to
avoid potential errors in EOA and mean gradient due to
changing hemodynamics in the early postexercise recovery
period. The EOA was then indexed for body surface area.
Data and statistical analysis. For each patient, the change
in valve EOA and mean gradient per change in transvalvular
flow rate during exercise was calculated to assess and
compare the flow dependence of these parameters in stent-
less bioprostheses versus in stented bioprostheses (16–18).
Data were expressed as mean 6 SD and compared using
a two-way analysis of variance for repeated measures fol-
lowed by the Tukey test to evaluate the effects of exercise
and bioprosthesis type (stentless vs. stented). If the normal-
ity test or the equality of variance test failed, the analysis of
variance was performed on the logarithmic transform of the
data. Statistical analysis of the association of variables was
performed with the Pearson correlation coefficient or the
determination coefficient adjusted for degrees of freedom
when the relation was linear or nonlinear, respectively.
Graphs were constructed with the corresponding regression
equation using a curve-fitting software (Table Curve, Jandel
Scientific, San Rafael, California). Values of p , 0.05 were
considered significant.
A forward stepwise regression analysis was performed to
identify factors that significantly influenced the change in
valve EOA during exercise. The relevant variables tested for
this analysis were: patient age and gender, prosthesis size,
type of bioprosthesis, time interval since prosthesis implan-
tation, mean flow rate, EOA and indexed EOA at rest and
changes in mean flow rate and systolic blood pressure with
exercise.
RESULTS
Measurement feasibility. Of the 50 patients recruited for
the study, 38 patients achieved maximal exercise. The
exercise test was stopped prematurely because of excessive
blood pressure rise in seven patients and ST-segment
depression in one patient. In addition, one patient stopped
because he did not tolerate the mouth piece and three
patients stopped because of claudication. Transvalvular flow
velocity could be adequately measured in 37 of the 38
patients who completed the maximal exercise test, whereas
it was possible to measure LVOT flow velocity (and
therefore EOA and mean gradient) in 30 of the 38 patients.
Patients clinical characteristics. Table 1 shows the pre-
operative and operative data for the 38 patients who
completed the maximal exercise study. These data show no
significant difference between the two groups and as well,
the patients operated on for dominant aortic stenosis had no
difference in preoperative mean gradient (50 6 21 vs. 47 6
18 mm Hg) or indexed EOA (0.36 6 0.07 vs. 0.37 6
0.07 cm2/m2), and the patients operated on for dominant
aortic regurgitation or mixed dysfunction had no difference
in the severity of regurgitation.
Left ventricular morphology and function. Table 2 shows
that, at the time of the exercise study, several parameters of
LV morphology and function were significantly better in the
patients with a stentless bioprosthesis as compared with the
patients with a stented prosthesis. Moreover, on the basis of
the criteria (LV mass index .110 g/m2 for women and
.134 g/m2 for men) proposed by Devereux et al. (19), 1 of
19 (5%) patients with a stentless bioprosthesis had LV
hypertrophy compared with 6 of 19 (32%) of patients with
a stented bioprosthesis.
Maximal exercise capacity. Maximal exercise capacity as
estimated by maximal workload, peak VO2 or anaerobic
threshold did not significantly differ between patients with a
stentless bioprosthesis and those with a stented bioprosthe-
sis (Table 3).
Validation of echocardiographic measurements. There
was a strong correlation and agreement between the resting
EOA measured in the supine position and that measured in
the upright sitting position: EOA upright 5 0.10 1
(0.95 3 EOA supine), r 5 0.97, standard error of estimate
(SEE) 5 60.14 cm2, p , 0.001). There also was a very
good correlation (r 5 0.83, SEE 5 61.19 L/min, p ,
0.001) between VO2 and the cardiac output measured by
Doppler echocardiography at peak exercise.
Baseline Doppler echocardiographic data (Table 4). In
the upright rest position, patients with a stentless biopros-
thesis had similar cardiac index and mean transvalvular flow
rate but higher valve EOA and lower mean gradient when
compared with patients with a stented bioprosthesis. De-
spite a similar indexed prosthesis size in both groups (Table
1), the indexed EOA was significantly higher in stentless
bioprostheses, thus reflecting their superior hemodynamic
performance at rest.
Changes in Doppler echocardiographic data with maxi-
mal exercise (all patients). On average, cardiac index
increased by 123 6 41% (13.11 6 0.89 L/min/m2, p ,
0.001) and mean flow rate increased by 53 6 24% (1132 6
60 ml/s, p , 0.001), whereas EOA increased by 10 6 13%
(10.21 6 0.27 cm2, p , 0.001) and mean gradient
increased by 96 6 53% (18 6 7 mm Hg, p , 0.001) with
maximal exercise.
Comparison of stentless versus stented bioprostheses.
Despite similar increase in cardiac index and mean flow rate
with exercise, the patients with a stentless bioprosthesis had
significantly (p 5 0.002) less increase in mean gradient
(Table 4). The changes in gradient per change in flow rate
were also significantly lower in stentless bioprostheses
(14 6 4 vs. 113 6 10 mm Hg/100 mls21; p 5 0.002).
The EOA increased significantly with maximal exercise
in both groups and there was no significant difference
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between the groups for the change in EOA with maximal
exercise both in absolute (Table 4) and relative terms
(stented: 9 6 13% versus stentless: 11 6 14%, p 5 0.56).
There also was no significant difference between stentless
and stented bioprostheses in regard to the change in EOA
per change in flow rate (10.15 6 0.15 vs. 10.08 6 0.18
cm2/100 mls21; p 5 0.30). In multivariate analysis, the
change in mean flow rate with exercise was the only
independent determinant of the change in EOA during
exercise.








Female 5 (26.3%) 3 (15.8%)
Male 14 (73.7%) 16 (84.2%)
Age (yr) 65 6 11 64 6 7 NS
Body surface area (m2) 1.78 6 0.20 1.85 6 0.14 NS
Dominant valvular dysfunction NS
Stenosis 16 (84.2%) 14 (73.7%)
Regurgitation 1 (5.3%) 2 (10.5%)
Mixed dysfunction 2 (10.5%) 3 (15.8%)
Preoperative LV mass index (g/m2) 148 6 63 152 6 28 NS
Preoperative LV ejection fraction (%) 64 6 11 62 6 9 NS
Prosthesis size (mm) NS
19 1 (5.3%) 0 (0%)
21 2 (10.5%) 2 (10.5%)
23 2 (10.5%) 1 (5.3%)
25 8 (42.1%) 6 (31.6%)
27 5 (26.3%) 10 (52.6%)
29 1 (5.3%) 0 (0%)
Average 24.8 6 2.5 25.5 6 2.0 NS
Prosthesis size indexed for BSA (mm/m2) 14.0 6 1.5 13.9 6 1.5 NS
Time interval since implantation (yr) 4.1 6 2.2 3.0 6 1.2 NS
Blood pressure (mm Hg)
Systolic 140 6 22 138 6 18 NS
Diastolic 78 6 15 75 6 10 NS
Hypertension on therapy 5 (26.3%) 4 (21.1%)
Diabetes 1 (5.3%) 2 (10.5%)
Data presented are mean value 6 SD or number of patients. BSA 5 body surface area; LV 5 left ventricular; NS 5
nonsignificant.
Table 2. Comparison of Left Ventricular Morphology and Function at Rest Between Patients







End-diastolic dimension (mm) 48 6 5 45 6 2 0.02
End-systolic dimension (mm) 28 6 4 26 6 3 NS
End-diastolic septum thickness (mm) 13 6 4 12 6 2 NS
End-diastolic posterior wall thickness (mm) 11 6 2 11 6 3 NS
LV mass (g) 219 6 81 180 6 38 NS
LV mass index (g/m2) 122 6 42 99 6 19 0.04
Posterior wall thickening fraction 0.58 6 0.13 0.70 6 0.20 0.03
Posterior wall thickening velocity (s21) 1.63 6 0.44 2.16 6 0.69 0.008
Internal radius shortening fraction 0.42 6 0.05 0.42 6 0.06 NS
Mid-wall radius shortening fraction 0.23 6 0.03 0.21 6 0.05 NS
Longitudinal shortening fraction 0.17 6 0.10 0.25 6 0.10 0.02
Ejection fraction 0.72 6 0.07 0.75 6 0.07 NS
Peak systolic wall stress (kdynes/cm2) 114 6 35 78 6 23 , 0.001
Data presented are mean value 6 SD. LV 5 left ventricular; NS 5 nonsignificant.
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Dependence of exercise transvalvular gradients on rest-
ing indexed EOA. A strong inverse exponential relation
was found in all patients between the mean gradient either
at rest or during peak exercise and the resting indexed EOA
(Fig. 1, Panels A and B). As previously found in our study
of patients with a stented valve (3), there also was a strong
inverse correlation between the increase in gradient with
maximal exercise and the resting indexed EOA (Fig. 2).
However, in the previous study the relation was linear
whereas in this study, that included a group of patients with
a wider range of indexed EOA (0.56–1.75 cm2/m2 vs.
0.56–0.98 cm2/m2), this relation was exponential. The
analysis of Figures 1 and 2 shows that patients with a
stented or a stentless bioprosthesis were distributed on
different sections of the same exponential curves. Most
patients with a stented bioprosthesis had an indexed EOA
#0.85–0.90 cm2/m2 and were therefore on the steep
portion of the exponential curves. Consequently, in these
patients the gradient was relatively high at rest (Fig. 1, Panel
A) and increased markedly with maximal exercise (Fig. 2).
In contrast, most patients with a stentless bioprosthesis had
a larger indexed EOA at rest and were, therefore, on the flat
portion of the curves where the resting gradient was low and
little increase in gradient occurred during exercise.
DISCUSSION
Comparison with previous studies. Several studies in
patients with an aortic bioprosthesis have reported a signif-
icant increase in mean gradient during exercise, but impor-
tant variations were observed among patients, depending on
valve model and size (4,5,20–23). To our knowledge, this is
the first study that compared the hemodynamic perfor-
mance in patients with stented versus stentless bioprostheses
during maximal exercise. Previous studies in similar bio-
prostheses were performed during submaximal exercise,
and, in most cases, the EOA was not measured.
Hemodynamic performance of stentless versus stented
bioprostheses. This study definitely shows that stentless
bioprostheses have less increase in gradient during maximal
Table 3. Comparison of Maximal Workload and Oxygen Consumption During








Maximal workload (Watts) 118 6 53 129 6 41 NS
Rest VO2 (ml/kg/min) 4.4 6 0.8 4.0 6 0.7 NS
Anaerobic threshold (ml/kg/min) 12.7 6 3.6 14.7 6 3.9 NS
Peak VO2 (ml/kg/min) 25.8 6 8.2 27.2 6 6.8 NS
% of predicted peak VO2 110 6 29 112 6 32 NS
Data presented are mean value 6 SD. VO2 5 oxygen consumption; NS 5 nonsignificant.



















Cardiac index (L/min/m2) , 0.001 NS NS
Stented (n 5 14) 2.68 6 0.62 5.91 6 1.09† 13.18 6 0.71†
Stentless (n 5 16) 2.53 6 0.42 5.58 6 1.10† 13.04 6 1.05†
Mean flow rate (ml/s) , 0.001 NS NS
Stented (n 5 14) 256 6 50 383 6 105† 1125 6 65†
Stentless (n 5 16) 241 6 37 377 6 69† 1137 6 58†
Effective orifice area (cm2) , 0.001 , 0.001 NS
Stented (n 5 14) 1.46 6 0.32 1.60 6 0.49* 10.15 6 0.22*
Stentless (n 5 16) 2.15 6 0.45¶ 2.40 6 0.61¶† 10.26 6 0.30†
Indexed effective orifice area (cm2/m2) , 0.001 , 0.001 NS
Stented (n 5 14) 0.82 6 0.13 0.90 6 0.24* 10.08 6 0.12*
Stentless (n 5 16) 1.18 6 0.25¶ 1.32 6 0.36¶† 10.14 6 0.18†
Mean transvalvular gradient (mm Hg) , 0.001 , 0.001 NS
Stented (n 5 14) 13 6 5 25 6 11† 112 6 8†
Stentless (n 5 16) 5 6 4¶ 10 6 7¶† 15 6 3§†
*p , 0.05. †p , 0.001, exercise versus baseline. §p , 0.01. ¶p , 0.001, stentless versus stented bioprostheses.
NS 5 nonsignificant. Data presented are mean value 6 SD.
1613JACC Vol. 34, No. 5, 1999 Pibarot et al.
November 1, 1999:1609–17 Stentless Valve Hemodynamics During Exercise
exercise than stented bioprostheses, despite similar increases
in mean flow rate. In both cases, the EOA also increased
during exercise thus minimizing the increase in gradient
that could have occurred had the EOA remained constant.
In Figure 3, the solid lines are the relations between the
indexed EOA and the gradients observed at rest and during
exercise and the dashed line represents the gradients that
would have been observed during exercise given similar
increases in mean flow rates and constant EOAs. The
reduction in gradient due to the increase in EOA is in the
order of 24%. To explain the apparent discrepancy in the
order of magnitude between the increase in EOA (110 6
13%) and the reduction in gradient (224 6 10%), one must
remember that gradient is a squared function of flow and
EOA.
However, this study did not confirm our hypothesis
stating that stentless bioprostheses might have a greater
intrinsic capacity for EOA enlargement due to the flexibility
of their annulus. The Freestyle bioprosthesis is surrounded
by a polyester covering which might limit its potential to
expand with exercise.
Given these observations, the superior hemodynamic
performance of the stentless bioprostheses appears mainly to
Figure 1. Correlation between mean transvalvular gradient and
indexed EOA at rest in patients with a stentless (open circle) or a
stented (solid circle) bioprosthesis. Panel A and panel B show
this relation for mean gradient measured at rest and during peak
exercise, respectively. EOA 5 effective orifice area.
Figure 2. Correlation between the change in mean transvalvular
gradient with maximal exercise and indexed EOA at rest in
patients with a stentless (open circle) or a stented (solid circle)
bioprosthesis. EOA 5 effective orifice area.
Figure 3. Mean gradient observed at rest (lower solid line) and
during peak exercise (upper solid line) and expected mean
gradient at peak exercise (dashed line) as a function of indexed
EOA at rest. The exponential curves representing the observed
gradient at rest and during peak exercise were constructed using
the regression equations given in Figure 1. The curve representing
the expected behavior of gradient during maximal exercise (dashed
line) was derived from the resting curve (lower solid line)
assuming incremental increase in mean flow rate and a constant
EOA during exercise. EOA 5 effective orifice area.
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be related to a question of sizing, i.e., to their larger EOA
in relation to the patient’s body surface area resulting in a
larger EOA and a lower gradient at any given flow level.
This conclusion is strongly supported by the relations given
in Figures 1 and 2. A larger indexed EOA can be due either
to a larger EOA in relation to the prosthesis outer diameter
size or to the fact that, for the stentless bioprostheses, a
larger prosthesis can be inserted into a smaller patient, as
previously reported for the Freestyle and Toronto SPV
valves (St. Jude Medical, St. Paul, Minnesota) (1,24,25). In
this study, however, the indexed EOAs were much larger in
the stentless bioprostheses despite a similar average valve
size indexed for body surface area, suggesting that the main
factor in these patients was a larger EOA in relation to the
prosthesis outer diameter size.
Influence on exercise capacity and LV morphology. Al-
though stentless bioprostheses had better hemodynamics
than stented bioprostheses at rest and during exercise, there
was no difference in maximal exercise capacity between the
two groups. For all practical purposes, even in the patients
with the smallest indexed EOAs, the resting and exercise
gradients were similar to those observed in mild to moderate
aortic stenosis (18) and probably not high enough to affect
maximal exercise capacity.
Furthermore, our results suggest that the lesser gradients
observed at rest and during exercise in stentless bioprosthe-
ses might have a beneficial effect on LV mass and function.
Indeed, despite similar baseline characteristics, the patients
with a stentless bioprosthesis had a significantly smaller LV
mass than the patients with a stented bioprosthesis. This
result is consistent with the previous study of Jin et al. (2)
showing that stentless bioprostheses are associated with
greater decrease in LV wall stress and better regression of
LV hypertrophy than stented prostheses. The very signifi-
cant differences in posterior wall thickening and ventricular
longitudinal shortening also suggest a better recuperation of
subendocardial myocardial function in the patients with a
stentless bioprosthesis (7), which is also consistent with the
lower residual systolic wall stress found in these patients.
Further longitudinal studies are necessary to confirm these
findings as well as to determine their potential impact on
long-term morbidity and mortality.
Study limitations. Since Doppler echocardiographic mea-
surements were performed with the patient in the upright
position and during exercise, one cannot exclude completely
that the true maximal transvalvular velocities were not
always recorded. However, the very good correlation (r 5
0.90; p , 0.0001) obtained between the gradient during
maximal exercise and the indexed EOA at rest tends to
confirm a certain coherence in the results. The recordings of
the LVOT velocities and the measurement of the LVOT
diameter, which determine stroke volume, cardiac output
and EOA, can be affected by experimental conditions.
However, the strong correlation that we obtained between
the cardiac output measured at peak exercise by Doppler
echocardiography and peak VO2 supports the validity of
these measurements. Although Doppler echocardiographic
recordings during exercise, particularly those of LVOT
velocities, are technically demanding, this study shows that
they are feasible and reliable.
Most of the stented bioprostheses were Medtronic Intact
valves, whereas all the stentless bioprostheses were
Medtronic Freestyle bioprostheses. Other bioprosthetic or
mechanical valves may demonstrate different changes in
EOA with exercise and therefore different increases in
gradient given the same indexed EOA at rest. The power to
detect differences in EOA behavior during exercise is also
limited by the low number of patients in each group, but the
results nonetheless suggest that the change in gradient with
exercise is much more related to the resting EOA rather
than to its relative change during exercise.
Also, this study was carried out in a relatively homoge-
nous group of patients, i.e., sedentary patients between 55
and 75 years old with a normal LV systolic function. In a
more heterogeneous group of patients with regard to patient
age, LV function and physical training conditions, the
correlation between mean gradient and the resting indexed
EOA might have been lower than that observed in this
study. For instance, given the same indexed EOA at rest,
young athletes might have had a higher gradient than
predicted at peak exercise due to a supranormal cardiac
output, whereas inversely, older patients with depressed LV
function might have had lower gradients.
Clinical implications. These findings further confirm the
importance of valve sizing with regard to the hemodynamic
behavior of a prosthesis. Indeed, our results show that,
regardless of the type of bioprosthesis, the resting indexed
EOA is the best predictor of postoperative gradients
whether at rest or during exercise. Furthermore, the rela-
tions found in this study can be used to project postoperative
gradients at the time of operation and should thus be useful
to select the optimal prosthesis given a patient’s body surface
area and level of physical activity. Figure 4 illustrates the
relations between the resting and exercise gradients ob-
served in this study and the indexed EOAs calculated from
the patient’s body surface area and the published normal
values for the prosthesis being implanted (1), a calculation
that can be made in the operating room. The correlations
are slightly less significant than those shown in Figure 1,
probably due to differences in prosthesis manufacturing and
other unknown factors. Nonetheless, they show that these
postoperative gradients could have been predicted from
information available at the time of operation. They also
further confirm that the projected indexed EOA should
ideally be no less than 0.90 cm2/m2 in order to minimize
postoperative gradients. It should be emphasized that the
normal values for the EOA of stented bioprostheses were
taken from in vitro data whereas for the stentless biopros-
theses, these values were taken from in vivo data because it
has been shown that, contrary to stented bioprostheses, in
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vitro data for stentless bioprostheses grossly overestimate in
vivo EOAs (1).
Conclusions. Stentless bioprostheses have a better hemo-
dynamic performance than stented bioprostheses during
exercise mostly because of their larger resting EOA rather
than a greater intrinsic capacity for EOA enlargement. This
is associated with beneficial effects with regard to LV mass
and function. The strong exponential relations found be-
tween the resting indexed valve EOA and the gradients at
rest and during exercise further confirm that the postoper-
ative hemodynamic behavior of a bioprosthesis can largely
be predicted from this parameter at the time of operation.
These relations should therefore be useful to select the
optimal valve given a patient’s body surface area and level of
physical activity.
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